The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs, And More
January 30, 2021 at 14:57 PM EST
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis AG, Johnson & Johnson, and Eli Lilly And Co all in the mix.
